ABSTRACT SUBMISSION GUIDELINES 2021
ABSTRACT SUBMISSION DATES & DEADLINES
|
All Abstract Submissions Open
Deadline Registration Grant Application Registration Grant Recipients Notification Abstract Submission Deadline Abstract Approval Notification |
June 10th, 2021
July 16th, 2021 By September 15th , 2021 September 15th, 2021 By October 1st, 2021 |
ABSTRACT SUBMISSION GUIDELINES
Please follow the instructions listed below:
● All abstracts can be submitted through our Abstract Submission Portal.
● Abstracts must be received by the announced deadline End of Business day (CEST). Abstracts received after the deadlines will not be considered.
● Please keep in mind there is a different deadlines for Registration Grant application.
● Submission of an abstract acknowledges the acceptance for the abstract to be published in the official meeting publications.
● Co-author approval is assumed to be approved with abstract submission.
● Presenting authors must be registered participants at least 1 month before the conference. If this is not possible due to circumstances, please contact us at [email protected].
● All applicants must currently work or study in the field of respiratory infectious diseases, and must provide information regarding position/title.
● Abstracts must be related to RSV and fit to 1 of the 4 categories:
● Vaccines, Therapies, & Treatments
● Clinical Studies
● Evolution & Epidemiology
● Virology & Immunology
● Abstracts must be submitted and presented in English.
● Maximum of 250 words, otherwise abstract will not be accepted.
● Abstract submitters will be required to disclose any conflict of interests in the submission form.
● Please indicate if you wish to participate in the Young Researchers’ Tournament (more information here).
● You should receive email confirmation within 1 working day of submitting your abstract. If, after checking your spam folder, you have not received this confirmation, then please contact [email protected].
● Questions regarding abstract policy, deadlines, notifications, programming, general conference questions, contact [email protected].
● All abstracts can be submitted through our Abstract Submission Portal.
● Abstracts must be received by the announced deadline End of Business day (CEST). Abstracts received after the deadlines will not be considered.
● Please keep in mind there is a different deadlines for Registration Grant application.
● Submission of an abstract acknowledges the acceptance for the abstract to be published in the official meeting publications.
● Co-author approval is assumed to be approved with abstract submission.
● Presenting authors must be registered participants at least 1 month before the conference. If this is not possible due to circumstances, please contact us at [email protected].
● All applicants must currently work or study in the field of respiratory infectious diseases, and must provide information regarding position/title.
● Abstracts must be related to RSV and fit to 1 of the 4 categories:
● Vaccines, Therapies, & Treatments
● Clinical Studies
● Evolution & Epidemiology
● Virology & Immunology
● Abstracts must be submitted and presented in English.
● Maximum of 250 words, otherwise abstract will not be accepted.
● Abstract submitters will be required to disclose any conflict of interests in the submission form.
● Please indicate if you wish to participate in the Young Researchers’ Tournament (more information here).
● You should receive email confirmation within 1 working day of submitting your abstract. If, after checking your spam folder, you have not received this confirmation, then please contact [email protected].
● Questions regarding abstract policy, deadlines, notifications, programming, general conference questions, contact [email protected].
ABSTRACT SUBMISSION PREPARATION
Before you begin, please prepare the following information:
- Interest in being considered for Early Career Researchers’ Tournament
❏ Must upload documentation of your institution’s letterhead with a letter from the
department head confirming current position. - Presenting Author Details:
❏ Full First & Last Name (ex. John C. Smith)
❏ Email Address
❏ Postal Address (city, state if relevant, country)
❏ Daytime & Evening Phone Numbers - Affiliation Details of Presenting Author:
❏ Position / Title
❏ Department & Institution / Hospital - Category of Abstract:
❏ 1) Vaccines, Therapies, & Treatments
❏ 2) Clinical Studies
❏ 3) Evolution & Epidemiology
❏ 4) Virology & Immunology - Abstract Title:
❏ Limited to 25 words in UPPERCASE (ex. ABSTRACT ON CLINICAL STUDIES) - Abstract Text:
❏ Limited to 250 words (including acknowledgements)
ABSTRACT SUBMISSION LINK
Abstracts should be submitted via our Abstract Submission Portal.
